Medications for daytime sleepiness in individuals with idiopathic hypersomnia

• Type of Material: Article
• Authors: Lorne A. Becker, State University of New York Upstate Medical University; Catherine Friederich Murray, Hypersomnia Foundation; Romy Hoque, Emory University; Lynn Marie Trotti, Emory University
• Language: English
• Date: 2017-07-12
• Publisher: Cochrane Collaboration
• Publication Version: Final Published Version
• Copyright Statement: © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• Final Published Version (URL): http://dx.doi.org/10.1002/14651858.CD012714
• Title of Journal or Parent Work: Cochrane Database of Systematic Reviews
• ISSN: 1469-493X
• Volume: 2017
• Issue: 7
• Grant/Funding Information: National Institute for Health Research (NIHR), UK.; National Institutes of Health, USA.;K23 NS083748 (to LMT)
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of medications for daytime sleepiness and related symptoms in individuals with idiopathic hypersomnia, and in particular whether medications may: reduce subjective measures of sleepiness; reduce objective measures of sleepiness; reduce symptoms of cognitive dysfunction; improve quality of life; and be associated with adverse events.